PHARMACEUTICAL STUDIES ON VITAMIN D DERIVATIVES AND PRACTICAL SYNTHESES OF SIX COMMERCIALLY AVAILABLE VITAMIN D DERIVATIVES THAT CONTRIBUTE TO CURRENT CLINICAL PRACTICE

被引:24
作者
Kubodera, Noboru [1 ]
机构
[1] Chugai Pharmaceut Co Ltd, Chuo Ku, Tokyo 1038324, Japan
关键词
Vitamin D; Active Vitamin D; Active Vitamin D Derivative; Pharmaceutical Study; Practical Synthesis; ACTIVE FORMS; D ANALOGS; UREMIC RATS; MAXACALCITOL; 1-ALPHA; 25-DIHYDROXYVITAMIN-D3; 19-NOR-1,25-(OH)(2)D-2; HYPERPARATHYROIDISM; DIFFERENTIATION; LINKAGE; POTENT;
D O I
10.3987/REV-09-SR(S)3
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Three milestones exist in vitamin D research from the perspective of pharmaceutical development. The article first discusses the various milestones outlining vitamin D and derivatives in terms of pharmaceutical applications. Several active vitamin D derivatives based on the findings during the third milestone are now commercially available and contributing to current clinical practice. The paper also reviews the practical syntheses of six derivatives, maxacalcitol, calcipotriol, tacalcitol, paricalcitol, doxercalciferol, and falecalcitriol, as well as summarizes future prospects for further drug development.
引用
收藏
页码:83 / 98
页数:16
相关论文
共 33 条
[31]  
STERN PH, 1984, J PHARMACOL EXP THER, V229, P9
[32]   A new analog of 1,25-(OH)(2)D-3, 19-NOR-1,25-(OH)(2)D-2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content [J].
Takahashi, F ;
Finch, JL ;
Denda, M ;
Dusso, AS ;
Brown, AJ ;
Slatopolsky, E .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (01) :105-112
[33]   26,26,26,27,27,27-HEXAFLUORO-1,25-DIHYDROXYVITAMIN-D3 - A HIGHLY POTENT, LONG-LASTING ANALOG OF 1,25-DIHYDROXYVITAMIN-D3 [J].
TANAKA, Y ;
DELUCA, HF ;
KOBAYASHI, Y ;
IKEKAWA, N .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1984, 229 (01) :348-354